Dynamic coronary stenoses may be the cause of a variable angina threshold and rest angina in patients with chronic stable angina. It has been suggested that eccentric but not concentric coronary artery stenoses have the potential for dynamic changes of caliber in response to vasoactive stimuli. The vasomotor response of eccentric (asymmetric narrowing) and concentric (symmetric narrowing) coronary stenoses to ergonovine (20 pg intra coronary or 300 pg intravenous) and isosorbide dinitrate (1 mg intracoronary) was studied in 51 patients with chronic stable angina. Diameter of reference segments (angiographically normal segments proximal to the stenoses) and that of eccentric (n = 30) and concentric (n = 35) coronary stenoses that ranged from 50% to 90% luminal diameter reduction were measured by computerized quantitative angiography before and after ergonovine and isosorbide dinitrate.
Dynamic coronary stenoses may be the cause of a variable angina threshold and rest angina in patients with chronic stable angina. It has been suggested that eccentric but not concentric coronary artery stenoses have the potential for dynamic changes of caliber in response to vasoactive stimuli. The vasomotor response of eccentric (asymmetric narrowing) and concentric (symmetric narrowing) coronary stenoses to ergonovine (20 pg intra coronary or 300 pg intravenous) and isosorbide dinitrate (1 mg intracoronary) was studied in 51 patients with chronic stable angina. Diameter of reference segments (angiographically normal segments proximal to the stenoses) and that of eccentric (n = 30) and concentric (n = 35) coronary stenoses that ranged from 50% to 90% luminal diameter reduction were measured by computerized quantitative angiography before and after ergonovine and isosorbide dinitrate.
Ergonovine reduced stenosis diameter (by 2:10%) in 80% of eccentric stenoses and 42% of concentric stenoses (p < 0.05).
Mean (± SEM) diameter reduction with ergonovine was 19 ± 3%
It has become apparent (1) (2) (3) (4) that a large proportion of patients with chronic stable angina have a variable threshold for the provocation of their exertional angina and may also have angina at rest or with levels of exertion usually well tolerated by the patient. It has been suggested (1-7) that this is caused by episodic coronary vasoconstriction superimposed on critical atheromatous coronary obstructions. Several studies (6, (8) (9) (10) (11) (12) (13) have documented the ability of coronary stenoses to alter their caliber dynamically in response to vasoactive stimuli. It has been suggested that eccentric stenoses, which retain a variable arc of disease-free wall (14, 15) , but not concentric lesions (16) , in which the atherosclerotic plaque involves the entire circumference of the artery, have the potential to dilate in response to nitrates and calcium channel antagonists. It has been proposed (6, 10, 17) that subtle variations of coronary tone at the site of significant eccentric stenoses may cause marked changes in the (p < 0.05). Isosorbide dinitrate increased coronary diameter (by ~10%) in 70% of eccentric and 43% of concentric stenoses (p < 0.05). Mean diameter of eccentric stenoses increased from 1.15 ± 0.05 to 1.35 ± 0.06 mm after nitrate (18.6 ± 2.5%), whereas diameter of concentric stenoses increased from 1.05 ± 0.05 to 1.14 ± 0.05 mm (10 ± 2.5%) (p < 0.05). Average dilation of reference segments with administration of isosorbide dinitrate and constriction with ergonovine were not significantly different in patients with concentric and eccentric stenoses. Thus, in patients with chronic stable angina, both eccentric and concentric stenoses have the potential for dynamic changes of caliber in response to vasoactive stimuli. However, a significantly larger proportion of eccentric stenoses exhibit this potential. The magnitude of dynamic changes of caliber is also larger in eccentric than in concentric stenoses.
(J Am Coil CardioI1991; 17:627-33) luminal caliber of the vessel and critical impairment of coronary blood flow. In chronic stable angina, it has been hypothesized (6,10,14-16) that the increment of coronary vasomotor tone that may cause a variable anginal threshold, with chest pain at levels of exertion usually well tolerated by the patient and occasional angina at rest, occurs at the site of eccentric stenoses. We studied the response of eccentric and concentric coronary stenoses to the administration of ergonovine or intracoronary isosorbide dinitrate, or both, in patients with chronic stable angina.
Methods
Study patients (Table 1) . Fifty-one of 62 consecutive patients with a history of chronic stable angina referred to our institution over a period of 5 months (February to June 1989) for coronary arteriography were included in the study. Of the other 11 patients, 3 had angiographically normal coronary arteries and 8 declined to participate in the study. All 51 participating patients had chronic stable exertional angina, defined as typical effort angina relieved by rest or nitrates, with no change in symptoms in the 6 months preceding admission to the study, and angiographically documented coronary artery disease (intraluminal coronary Table 1 . Study protocol. In every patient all antianginal medication was discontinued before the study, with the exception of sublingual nitrates, which were allowed for relief of anginal episodes. Nitrates and calcium channel antagonists were discontinued 48 hours before the study, and beta-adrenergic blockers at least 72 hours before the study. All patients were fasting, had not smoked and had not received sublingual nitrates for acute pain for at least 8 hours before cardiac catheterization. After diagnostic coronary arteriography, orthogonal views of the coronary arteries with stenotic lesions (:2:50%) were obtained before administration of ergonovine and nitrates (control coronary arteriograms). Ergonovine was given to the first 20 patients included in the study, irrespective of type of angina (20 Jlg intracoronary in 6, and 300 Jlg intravenous in 14); coronary injections were repeated 3 to 4 min after ergonovine administration or earlier if angina or ST segment depression developed. In four patients angina or 1 mm of ST segment depression, or both, developed in response to ergonovine; these conditions rapidly resolved with administration of intracoronary nitrates.
Intracoronary isosorbide dinitrate (1 mg) was administered to all patients; in 31 as the only vasoactive stimulus, after the control arteriogram, and in 20 after administration of ergonovine. In the four patients in whom angina or ST segment depression, or both, developed with ergonovine, isosorbide dinitrate was administered immediately; in the other 16 patients isosorbide dinitrate was given after a second control angiogram, which was obtained 5 to 7 minutes after ergonovine. Therefore, control coronary angiograms were obtained before the administration of nitrate in every patient, with the exception of the four who required nitrates for the relief of ergonovine-induced ischemia; in these patients baseline diameter was used as control for both ergonovine and nitrate administration. In all patients coronary arteriography was repeated 2 to 4 min after nitrate administration to assess its effect on coronary artery stenoses and reference segments. Sixty-five of 102 coronary stenoses observed in these patients were suitable for analy-SIS.
Every patient gave written informed consent before study entry. The study protocol was approved by the hospital's ethics committee.
Coronary arteriography. The Judkins technique was used for coronary arteriography in all patients. In every case diagnostic arteriography was carried out using standard views; then, each coronary artery was selectively imaged in at least two orthogonal projections. An angiographically normal proximal. juxtaposed segment (reference segment) was used to determine the percent stenosis of the diseased segment. A stenosis was considered critical if intraluminal coronary diameter was reduced by :2:50%. Sixteen patients had one vessel, 24 had two vessel and II had three vessel disease ( Table 1) .
Measurement of coronary diameters and assessment of stenosis morphology. Our technique of measuring coronary artery diameter has been reported previously (18) . Briefly, coronary luminal diameter was measured by an automated edge contour detection computerized system (Coronary Angiography Analysis System [CAAS], Pie Data Medical). The size of the stem of the Judkins coronary catheter was used for calibration to determine absolute measurement in millimeters and correction was made for radiographic pincushion distortion. Coronary arteriograms were analyzed by two independent observers and reanalyzed much later, without knowledge of previous assessments, to determine reproducibility of the method. No significant difference in the variances between analyses was found.
Coronary stenoses were morphologically classified as concentric or eccentric by two independent observers, on the basis of qualitative analysis of every lesion in at least two orthogonal projections. Concentric stenoses were those producing symmetric narrowing of a coronary artery. The borders of these lesions were smooth and their appearance was identical or almost identical in orthogonal projections. Eccentric stenoses were asymmetric narrowings of a coronary artery. Borders were smooth or irregular in these lesions and no attempt was made to further subdivide asymmetric lesions. Discrepancies arose in five patients. and the lesions were classified by consensus. The reproducibility for classifying a stenosis in its morphologic subset was determined by repeat evaluation of all films without knowledge of the first reading. Ninety-two percent of all stenoses were read in an identical fashion; 8% were classified by consensus after the second reading. The qualitative classification of stenosis type given by the two observers was compared with computerized stenosis symmetry measurements of the same coronary lesions carried out with an automatic edge detection system (CAAS system) (19) . Sixtytwo (95%) of the 65 stenoses were classified in an identical fashion both by the two independent observers and by the computer system. If the intraluminal diameter of stenoses changed by ~10% from the value control in response to isosorbide dinitrate or ergonovine. they were considered "dynamic. "
The percent change in coronary artery diameter was calculated as follows: Percent vasoconstriction by ergonovine = {(Control diameter -diameter after ergonovine)/ Control diameter} x 100 (%). Percent vasodilatation by nitrate = {(Diameter after nitrate -Control diameter)/ Control diameter} x 100 (%).
Data analysis. Data are presented as mean values ± SEM. Differences between proportions were analyzed by the Yates corrected chi-square test. Paired and unpaired Student's t tests were used to analyze continuous data. A p value < 0.05 was considered significant.
Results
Stenosis morphology ( Table 1) . Sixty-five (64%) of 102 coronary artery stenoses (35 concentric and 30 eccentric) observed in these 51 patients were suitable for quantitative analysis, and results reported here refer to these stenoses. Twenty-three (45%) of the 51 patients had concentric stenoses only, 20 (39%) had eccentric stenoses only. and eight (16%) had both concentric and eccentric stenoses. Severity of coronary stenoses for the whole group ranged from 50% to 95% (mean 75 ± 3%) luminal diameter reduction; the latter was not significantly different in concentric and eccentric stenoses (74 ± 2% and 75 ± 2.5%. respectively).
Response of eccentric and concentric stenoses to ergonovine ( Table 2) . Mean aortic pressure and heart rate did not change after intracoronary ergonovine but increased by 5 mm Hg with intravenous ergonovine. Four of the 20 patients (two with concentric and two with eccentric stenoses) who underwent ergonovine testing had ST segment depression. three of whom had angina. Symptoms and electrocardiographic (ECG) changes were promptly relieved by administration of intracoronary nitrates. None of the four patients had coronary artery occlusion with ergonovine, but all showed mild diffuse coronary constriction within the range observed in the whole group. In these patients luminal diameter of eccentric stenoses decreased more significantly than that of concentric stenoses (20.2 ± 4% versus 11.4 ± 2.5%). Baseline stenosis severity was not significantly larger in these four patients than in the 16 who did not have symptoms with ergonovine (80 ± 3 versus 76 ± 4%, respectively). Three had three vessel and one patient had two vessel disease; their exercise tolerance was significantly lower than that of the other patients receiving ergonovine. With ergonovine eight (57%) of 14 reference segments to concentric stenoses and six (60%) of 10 reference segments to eccentric stenoses had a luminal diameter reduction of at least ~ 10% (p = NS). Average coronary constriction was similar in the reference segments to eccentric and concentric stenoses (10.3 ± 2% and 10.6 ± 2%. respectively) (Fig. 1) .
A significantly larger proportion of eccentric than concentric stenoses were constricted by > /0% with ergonovine (80 l'erSliS 42%. respectively) (Fig. 2) . Concentric stenoses of 50% to 70% luminal diameter reduction had a degree of constriction after ergonovine similar to that of stenoses with more than 70% reduction (10.9 ± 3.5% and 9.2 ± 3%. respectively); a similar response was observed in eccentric coronary stenoses (12 ± 4 and 18 ± 4%. respectively, p = Figure 1 . Diameter change of reference segments with the administration of isosorbide dinitrate (ISDN) and ergonovine. The response of reference segments to these two vasoactive agents was not significantly different. NS). However, stenosis constnctlOn in response to ergonovine was, on average, significantly larger in eccentric than in concentric stenoses (19 ± 3 versus 9.5 ± 2, p < 0.05) (Fig. 3 , Table 2 ).
Response of eccentric and concentric stenoses to isosorbide dinitrate (Table 2 ). Intracoronary isosorbide dinitrate had no effect on mean aortic pressure or heart rate. Only 12 (34%) of the 35 reference segments to concentric stenoses and 12 (40%) of the 30 reference segments to eccentric stenoses (p = NS) dilated 2: 10% with nitrate administration. Average coronary dilation was not significantly different in reference segments of concentric and eccentric stenoses (7.1 ± 3% and 10 ± 3%, respectively, p = NS) (Fig. 1) .
Seventy percent (21 of 30) of eccentric coronary stenoses and 43% (15 of 35) of concentric stenoses dilated by 2: 10% with the intracoronary administration of isosorbide dinitrate (p < 0.05) (Fig. 2) . After intracoronary isosorbide dinitrate, the average coronary luminal diameter of eccentric stenoses increased by 18.6 ± 2.5% (from 1.15 ± 0.05 to 1.35 ± 0.06 mm) and that of concentric stenoses increased by 10 ± Figure 3 . Response of eccentric and concentric coronary stenoses to the administration of ergonovine and isosorbide dinitrate (ISDN). A significantly larger change in luminal diameter was documented in eccentric than in concentric coronary stenoses. 2.5% (from 1.05 ± 0.05 to 1.14 ± 0.05 mm) (p < 0.05) ( Table   2 , Fig. 3 ). Dilation of concentric coronary stenoses with 50% to 70% diameter reduction and that of stenoses with> 70% reduction was not significantly different (9.8 ± 4% and 12 ± 5%, respectively). Similarly, the degree of vasodilation observed in eccentric coronary stenoses after isosorbide dinitrate was not significantly different in stenoses with :s70% and those with> 70% (17 ± 4 and 21.8 ± 3% diameter reduction, respectively). However, for any given degree of stenosis severity, dilation after isosorbide dinitrate was significantly greater in eccentric than in concentric coronary stenoses. In 31 of the 51 patients, isosorbide dinitrate was the only vasoactive substance tested, and in 20 it was given after ergonovine (2: 7 min after ergonovine in 16 patients and < 1 min of ergonovine in four). No significant differences were observed in the degree of stenosis vasodilation caused by isosorbide dinitrate, whether given alone or after ergonovine (15 ± 3 versus 12 ± 3%, respectively). Stenosis reactivity in patients who had both concentric and eccentric stenoses. In the eight patients found to have both concentric and eccentric coronary stenoses, isosorbide dinitrate increased the coronary diameter of concentric stenoses by 9.7 ± 4% (from 1.08 ± 0.06 to 1.15 ± 0.07 mm) and that of eccentric stenoses by 19.2 ± 3% (from 1.10 ± 0.05 to 1.32 ± 0.04 mm) (p < 0.05). Ergonovine reduced the luminal diameter of concentric stenoses in these patients by 10.2 ± 3% (from 1.15 ± 0.06 to 1.03 ± 0.05 mm) and that of eccentric stenoses by 19.9 ± 2.5% (from 1.16 ± 0.04 to 0.95 ± 0.07 mm) (p < 0.05).
Relation between stenosis morphology, stenosis reactivity and pattern of angina pectoris (Tables 3 and 4) . The prevalence of concentric and eccentric stenoses was not significantly different in patients with fixed angina threshold and variable threshold angina (mixed angina). Eighteen (47%) of the 38 patients with mixed angina had concentric, 16 had eccentric (42%) and 4 (11%) had both types of coronary stenoses. Of the 13 patients with a fixed angina threshold, 5 (38%) had concentric stenoses, 4 (31 %) had eccentric stenoses and 4 (31 %) had both concentric and eccentric stenoses (Table 3) . A total of 65 coronary stenoses were analyzed; 46 (22 eccentric and 24 concentric) in patients with mixed angina and 19 (8 eccentric and II concentric) in patients with fixed threshold angina (Table 4 ). In patients with mixed angina, 77% of eccentric stenoses and 46% of concentric stenoses showed changes in diameter ("dynamic behavior") in response to either isosorbide dinitrate or ergonovine (p = 0.07), whereas in patients with fixed threshold angina, 50% of eccentric and 27% of concentric stenoses were dynamic (p = 0.6) ( Table 4) . Dynamic behavior was found in 28 (61%) of all 46 coronary stenoses analyzed in patients with mixed angina and in 7 (37%) of the 19 stenoses analyzed in patients with fixed anginal threshold (p = 0.13). Dynamic behavior was found in 77% of eccentric stenoses in patients with mixed angina and in 50% of eccentric stenoses in patients with fixed threshold angina (p = 0.3) ( Table 4 ). The response of concentric stenoses did not differ significantly between patients with variable and those with fixed threshold angina.
Discussion
Our results indicate that in patients with chronic stable angina, not only eccentric coronary artery stenoses, which have an arc of vascular smooth muscle potentially able to react to vasoactive stimuli (14, 15, (20) (21) (22) , but also concentric stenoses have the potential for dynamic changes of caliber in response to vasoactive stimuli. Our data also confirm that a significantly larger proportion of eccentric than concentric narrowings dilate with intracoronary nitrates and constrict with intracoronary or intravenous ergonovine. The magnitude of these changes of caliber in response to both isosorbide dinitrate and ergonovine was significantly larger in eccentric than in concentric stenoses.
Reactivity of concentric and eccentric coronary stenosis. For the same degree of diameter reduction, vasomotility of eccentric stenoses was greater than that of concentric stenoses. These results are consistent with observations by Rafflenbeul et al. (9, 16) with regard to the capacity of eccentric stenoses, compared with concentric stenoses, to dilate in response to nitrates and calcium antagonists. However, these investigators reported that eccentric stenoses, but not concentric lesions, dilated in response to calcium antagonists and nitrates. In our patients, although eccentric stenoses exhibited, on average, a larger vasomotor potential than did concentric stenoses, a substantial proportion of concentric stenoses also had the potential for vasomotor changes of coronary caliber. That concentric coronary stenoses also can be reactive structures is in agreement with results obtained by Ginsburg et al. (23) in isolated human epicardial coronary arteries. However, these investigators reported that in vitro, the contractile responses to vasoactive drugs were similar in segments with eccentric and concentric stenoses.
The present study and studies of others (9, 16, 24) show that eccentric stenoses can more readily change their coronary diameter than can concentric stenoses. This is probably because eccentric stenoses retain an arc of normal vascular smooth muscle (14) able to react to vasomotor stimuli, whereas concentric stenoses tend to be "fixed," as their vasomotility is limited by the involvement of the whole circumference of the artery in the atherosclerotic process. Less smooth muscle is available in concentric stenoses to respond to vasoactive stimuli (14) . This is important because the extent to which dynamic augmentation or contraction of the coronary lumen is possible appears to be a function of the extent and location of smooth muscle in the coronary wall. Some angiographically concentric stenoses, however, may retain sufficient smooth muscle to enable them to constrict or dilate, as found in our study, when challenged with ergonovine or isosorbide dinitrate. Our results indicate that, on average, the morphologic appearance of a coronary lesion correlates with its ability to alter its caliber dynamically, although there are many exceptions. Thus, in this study approximately 40% of concentric stenoses showed vasomotor potential and 20% of eccentric stenoses did not have such potential. Why some eccentric stenoses cannot react in response to vasodilator or constrictor stimuli is a matter of speculation, but may be related to the amount and distribution of the residual vascular smooth muscle and its functional capacity to react to vasoactive stimuli. The different behavior of eccentric and concentric stenoses observed in this study was not related to a different vasomotor capacity of the coronary tree in different patients, as reference segments to both eccentric and concentric stenoses exhibited a similar vasomotor response when challenged with ergonovine or after the administration of isosorbide dinitrate. Furthermore, we observed that within individual patients the magnitude of changes of vasomotor tone was significantly larger in eccentric than in concentric stenoses.
Severity of coronary stenosis and vascular reactivity. Our findings indicate that the different response of concentric and eccentric stenoses does not depend on the severity of the coronary atherosclerotic narrowing; stenosis severity (average diameter reduction) was similar in concentric and eccentric stenoses. Indeed, the degree of response to ergonovine and nitrates was similar in concentric stenoses with ::;70% diameter reduction and concentric stenoses with >70% reduction. Eccentric stenoses with ::;70% diameter reduction and those with> 70% diameter reduction also showed a comparable response to nitrates and ergonovine. These findings are in agreement with those of Rafflenbeul et al. (9) , who reported that "the chance for a beneficial response to nitrates is as good in a stenosis with high degree of obstruction as in a stenosis with low degree of obstruction," and with findings by Brown et al. (25) , who observed that both mild and severe coronary stenoses can dilate with sublingual nitroglycerin. Our results are also consistent with those obtained by Saner et al. (14) with computerized planimetry. They observed that the percent of disease-free wall arc length in eccentric stenoses did not differ significantly with increasing severity of coronary luminal obstruction. with location of the lesion within the same or different arteries. or among coronary segments with different diameters.
Clinical implications. Although we did not find a significant correlation between the pattern of angina and stenosis reactivity, there was clearly a trend for patients with a variable anginal threshold to have a larger proportion of dynamic stenoses than that of patients with a fixed anginal threshold. Limitations of this study did not allow accurate assessment of the relation between clinical presentation and stenosis reactivity; in particular. the fact that only 60% of all coronary lesions present in our patients were suitable for analysis and that a large proportion of patients had significant two or three vessel disease. Occasionally. a patient had more than one type of stenosis, making it impossible. in some cases, to identify the coronary lesion responsible for the anginal symptoms. Furthermore. only a few patients in this study had a fixed exertional anginal threshold. Large series including consecutive patients with chronic stable angina and single vessel disease are needed to assess the correlation between clinical presentation and stenosis reactivity and morphology.
Assessing stenosis morphology and reactivity on an angiographic basis apparently is not a major problem. particularly with the new angiographic systems that allow imaging of the coronary arteries in mUltiple views, even during exercise (13) . Quantitative information regarding the behavior of concentric and eccentric stenoses may help to explain the variable clinical presentations of chronic stable angina and may also provide the basis for rational antianginal therapy.
The contribution of changes of coronary vasomotor tone to myocardial ischemia in patients with variable threshold angina is further suggested by the observation in some of our patients that stenosis vasoconstriction (not coronary spasm) induced by ergonovine caused transient myocardial ischemia. These observations are in agreement with the results of our previous studies (7, 8, (26) (27) (28) and those of other investigators (6,9,10,13,16.29) that suggest that dynamic changes of caliber at the site of critical pliable coronary artery stenoses. whether concentric or eccentric. modulate the ischemic response of patients with chronic stable angina. Dynamic coronary stenoses, however, are not the only cause of mixed angina, as a variable anginal threshold has been observed also in patients who do not have the substratum for dynamic stenoses, such as those with an occluded coronary artery and collateral circulation arising from normal coronary vessels (30) . In these patients dynamic changes of small intramyocardial and collateral vessels have been shown to be responsible for the variable angina threshold (30) .
We thank Jean Powell for preparing the illustrations for this manuscript.
